News Focus
News Focus
Followers 48
Posts 23547
Boards Moderated 0
Alias Born 09/16/2012

Re: flipper44 post# 421992

Sunday, 11/28/2021 11:30:40 AM

Sunday, November 28, 2021 11:30:40 AM

Post# of 821980
And none of that can effectively be PR'd to avoid selling all their shares at all time lows?

You're basically saying they stalled out for five years of saving lives because of something that cost less than $2 million to develop?? Even with an army of smart h5 technicians under U.S. / UK supervision, somehow couldn't produce DCVAX "affordably" without the $1.4M gadget?

Pseudo progression has been an issue for decades. Any patient and good doctor knows when a tumor is in remission vs. growing. So, how convenient Flaskworks and the new progression detection methods theory moves along all at the same time.

Not buying any of it. Just Google GBM survivors over the last ten years and you'll find a sea of people doing well on all types of treatments, of which DCVAX rarely appears.




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News